by healthadvances Posted on August 6, 2021August 9, 2021 Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better? Read More
by healthadvances Posted on May 6, 2020 The Changing Fortunes of Telemedicine in Europe – Past, Present, and Future beyond COVID-19 Read More
by healthadvances Posted on April 16, 2020April 16, 2020 US SARS-CoV-2 Testing Response: What can be learned from South Korea and Germany? Read More
by healthadvances Posted on April 13, 2020April 20, 2020 Medtech Geographic Launch Sequences Warrant Reevaluation Read More
by healthadvances Posted on March 24, 2020April 13, 2020 e-Health in France: Spotlight on the National Healthcare Digitalization Strategy Read More
by healthadvances Posted on March 10, 2020April 13, 2020 ATTD 2020 – Transforming Diabetes Care Through Technology Read More
by healthadvances Posted on January 14, 2020April 13, 2020 Bridging the Gap in Clinical and Economic Evidence for Digital Health Tech in the UK Read More
by healthadvances Posted on July 23, 2019December 7, 2021 E-Health in Germany: Three New Laws Signify the Imminent Transformation to a Digitalised Healthcare System Read More
by healthadvances Posted on November 9, 2018April 13, 2020 Health Advances Presentation at ISPOR: Findings from the First Five Years of the NICE HST Program for Ultra Rare Conditions Read More
by healthadvances Posted on October 2, 2018April 13, 2020 E-Health in Germany: Rapid Progression of Digitalisation? Read More
by healthadvances Posted on September 18, 2018April 13, 2020 New Assessment Pathway for Invasive High-Risk Medical Devices in Germany: Balancing Market Access, Evidence and Patient Benefit Read More
by healthadvances Posted on August 23, 2018April 13, 2020 Disease Management Programs (DMPs) in Germany: The Importance of Guideline Inclusion for Chronic Therapies Read More
by healthadvances Posted on July 19, 2018April 13, 2020 The Medicines Optimisation Program in England Read More
by healthadvances Posted on May 3, 2018April 15, 2020 Patient Advocacy Groups as a Strategy for Orphan Drug Access in the UK Read More
by healthadvances Posted on April 10, 2018April 15, 2020 PCSK9 Inhibitors’ Battle for Reimbursement: Germany’s Decision and Implications in Other Countries Read More
by healthadvances Posted on March 13, 2018April 15, 2020 The Accelerated Access Review in the UK: Quicker Access to Innovative Drugs and Diagnostics, Medical and Digital Technologies Read More